Tibet Cheezheng Tibetan Medicine Co., Ltd.

¥19.37As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002287Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (1.97%)
Div yield 3.30%
ROE 12.71%
Biotechnology
Beta (5Y) 0.24
PE TTM 17.38
TSR TTM (21.88%)
Mkt cap ¥10.98B
ROIC 13.76%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥25
26.89%
(43.33%)
Hold 12|4|6|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.18
0.19
0.19
7.47%
(1.06%)
2.36%
3.42%
Revenue¥M
663.7
682.9
709.8
689.3
8.46%
10.78%
9.91%
2.67%
Peers (US$1.646B)
Cap (US$)
PE
1.713B
—
1.672B
5.690x
Capital
TTM
5Y
10Y
Leveragex
1.315
0.684
0.448
EBIT/Intx
10.58
1.596
1.147
Own earn%
(57.00)
(13.13)
(14.64)
Sh yield%
23.44
45.95
45.45
Owners
Insiders/Inst%
9.30
44.10
Short interest%
3.37
SBC / revenue%
1.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
15–18
$1 testx
—
Incr. ROIC%
4